The Crossroad for BioTransfer 2010
Life Science Technologies Ready-to-Go!
On May 18, 2010
At the Joseph B. Martin Conference Center at Harvard Medical School
75 Avenue Louis Pasteur, Boston, MA
The Crossroad for BioTransfer is a unique event showcasing the technological offerings of four research-intensive centres. The event brings together the biotechnology and biopharmaceutical sector, business leaders and the scientific community.
For this third edition, The Massachusetts Technology Transfer Center (MTTC) is partnering with the National Research Council Canada (NRC), McGill University and the Research Institute of the McGill University Health Centre, Gestion Univalor, Limited Partnership and Université de Montréal to present high-impact licensing opportunities in life sciences and health.
|
 |
The 2010 BioTransfer Award Winners
The Crossroad for BioTransfer 2010
The Crossroad for BioTransfer will showcase over 35 licensing opportunities in the health technology portfolios from the NRC, McGill University, Gestion Univalor and the MTTC. Attendees will be able to schedule meetings with the presenting organizations in order to assess high impact innovations and commercial endeavours. The Crossroad for BioTransfer provides a unique one-stop venue for biotechnology and pharmaceutical companies, entrepreneurs and the venture capital community to gain access to intellectual property emerging from research intensive universities and research institutes. It will be an outstanding forum for stakeholders to identify technology that promise to advance their drug discovery capability and enhance their product portfolio.
Objectives
- To provide a central meeting point for technology transfer professionals and business leaders from the biotechnology and biopharmaceutical sector, and venture capital community;
- To foster building relationships and commercial endeavours between research intensive centers and the private sector in the Boston area.
Technologies
The four co-organizers of The Crossroad for BioTransfer are premier organizations with solid track record of research and marketable innovation. Together they represent over 8,000 investigators engaged in cutting edge research in life sciences and a research budget totalling 5.5 billion dollars. For the event, they will showcase health technologies in the following specialty areas:
- Novel biopharmaceuticals broadly defined as "the convergence of biotechnologies and pharmaceutical science for the development of clinical candidates discovered or produced using biotechnology including chemical entities, vaccines, biologics and biomarkers for therapeutics and diagnostic purposes";
- Technology platforms for drug discovery, development, production and covering applications such as protein expression, drug delivery and gene markers.
Who Should Attend
Biotechnology and pharmaceutical professionals, business development executives, early stage companies, entrepreneurs and venture capital community seeking to expand, grow or start up new ventures.
Co-organizers
The Crossroad for BioTransfer event is organized by:
Montréal, Boston and Operational Support Committees
|
